AGIOS PHARMACEUTICALS, INC. ($AGIO)
Filing Information
| Accession Number | 0001439222-26-000034 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
25,665
Total Value
$64,378.08
P&L
+inf% (+$235,472.72)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 2,350 | $0.00 | $0.00 | 3,293 | Direct | โ | View Details | |
Principal Accounting Officer | Common stock | โ | Mar 2, 2026 | Sale | 698 | $28.96 | $20,214.08 | 2,595 | Direct | โ | View Details | |
Principal Accounting Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 2,450 | $0.00 | $0.00 | 4,970 | Direct | โ | View Details | |
Principal Accounting Officer | Common stock | โ | Mar 2, 2026 | Sale | 727 | $28.96 | $21,053.92 | 4,243 | Direct | โ | View Details | |
Principal Accounting Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 2,695 | $0.00 | $0.00 | 6,938 | Direct | โ | View Details | |
Principal Accounting Officer | Common stock | โ | Mar 2, 2026 | Sale | 798 | $28.96 | $23,110.08 | 6,140 | Direct | โ | View Details | |
Principal Accounting Officer | Restricted stock units | Derivative | Mar 1, 2026 | Grant/Award | 8,452 | $0.00 | $0.00 | 8,452 | Direct | โ | View Details | |
Principal Accounting Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 2,350 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Principal Accounting Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 2,450 | $0.00 | $0.00 | 2,450 | Direct | โ | View Details | |
Principal Accounting Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 2,695 | $0.00 | $0.00 | 5,390 | Direct | โ | View Details |